a:5:{s:8:"template";s:5073:" {{ keyword }}
{{ text }}
";s:4:"text";s:16153:"Overall HFD volume and value share stood at 65.7% and... GlaxoSmithKline Consumer Healthcare's (SKB) 1QFY20 operating performance is in line with our expectations. The management indicated that more focus will be on advertising rather than promotion going forward. stood at 43% (-110bp YoY, -30bp QoQ) while value market share for Boost stood at 10.8% (-50bp YoY, -10bp QoQ). The domestic business grew 10.8% on account of domestic volume growth of 8.7% Auxiliary income increased 20% YoY on the back of an improvement in OTC products and oral care portfolio performance. The market share of both Horlicks and Boost improved during the quarter and the overall HFD market share of the company stands at 64.6% in volume terms and 54.5% in value terms. Market share of both Horlicks and Boost improved YoY during the quarter. Touch device users, explore by touch or with swipe gestures. The Prices page of GlaxoSmithKline Consumer Healthcare Ltd.. captures the information on Price and Volume for a user defined time interval. Go premium! Raw material costs trend continued to remain favourable and this was one of the key reasons behind the expansion in operating margin by nearly 200bps YoY. It fluctuated in the first 10 days of the month and crossed the Rs.6,600 mark in the later half of the month. GlaxoSmithKline Consumer Healthcare Ltd. share price forecast The 4 reports from 3 analysts offering long term price targets for GlaxoSmithKline Consumer Healthcare Ltd. have an average target of 9373.33. Overall revenue grew by 5.7% YoY with domestic growth of ~7%, led by 3.6% volume growth YoY. (2) Pricing and deflation led to gross... and lower other expenses (-200bp YoY/ -380bp QoQ), partly offset by increased employee cost (+190bp YoY to 19.5%). from the last price of 10753.65. Its today's share price is 10753.65. GlaxoSmithKline Consumer Healthcare's (SKB) 3QFY20 revenue grew by 3.8% YoY to Rs11.6bn (vs our est. for GlaxoSmithKline Consumer Healthcare Ltd. have an average target of 9373.33. Stock analysis for GlaxoSmithKline Consumer Healthcare Ltd (SKB:Natl India) including stock price, stock chart, company news, key statistics, fundamentals and company profile. In March 2018, GlaxoSmithKline Plc had announced a strategic review of GSK Consumer Healthcare's (GSKCH) consumer nutrition business, including brands like Horlicks & Boost as the company was exploring a partial or full sale of its stake in GSKCH by end of 2018. Revenue decreased by 6.14% to Rs. Maintain YoY/+60bp QoQ) and at 11.5% for Boost (+70bp YoY/+10bp QoQ). In domestic business, base business and sachets grew around 9% and 20%, respectively, whereas food business declined 15% YoY. GlaxoSmithKline Consumer Healthcare's (SKB) 1QFY19 performance was marginally ahead of overall expectations. The sharp spurt in export sales was the function of a favourable base and foray into new markets like Malaysia. PAT grew by 32.6% to Rs2.77bn (vs our est. The 4 reports from 3 analysts offering long term price targets Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. Operating profit growth during... 15 February 2019 volume growth was 9.6% YoY. EBITDA grew 38% YoY to INR2.3b (our estimate: INR2.2b). It also contains the Live Stock Price and Volume, 52 Week High Low, Bid and Offer Price and Volume, Intraday and Historical Price Chart. The consensus estimate represents a downside of -12.84% from the last price of 10753.65. 1107.14 Cr in Q1FY19 when compared to the previous quarter GlaxoSmithkline Consumer Healthcare Ltd Q1FY19 results Comment. How good are your current hold decisions? - This broker has upgraded this stock from it's previous report.(eg. Volume market share (MAT Jun'19) for Horlicks/Boost stood at 50.9%/14.9%. - Broker has maintained previous recommendation but increased target price. 420,555,392. : INFY, WIPRO, News by Trendlyne All times stamps are reflecting IST (Indian Standard Time).By using this site, you agree to the Terms of Service and Privacy Policy. The Prices page of GlaxoSmithKline Consumer Healthcare Ltd.. captures the information on Price and Volume for a user defined time interval. Sorry, no quarterly data is available at this time. Middle East (ME) and Bangladesh are seeing slowdown (demand led as well as channel destocking) while political disruption in Pakistan also affected growth. Overall revenue grew by 8% YoY, led by volume growth of 5.4%, which was broadbased across channels and portfolio. - Sell->Hold). According to management, the focus on top-line growth may keep near- term margins under check. Glaxosmithkline Consumer Healthcare Ltd. - (Amalgamated) was incorporated in the year 1958. Adjusting for the same, PAT stood at INR1.2b (our estimate: INR961m).... GlaxoSmithKline Consumer Healthcare's (SKB) 4QFY19 operating performance was broadly in line with our expectations. All the regions are growing but North and West continue to grow at a faster pace compared to South and East. However, the scrip fell again and ended the month at Rs.6,476. On... GlaxoSmithKline Consumer Healthcare's (SKB) 2QFY19 operating performance was in line with our expectations, adjusted for the sharp surge in export sales. (eg. GlaxoSmithKline Consumer Healthcare Ltd. Share Price, Tata Consumer Products Ltd. shares decline 1.16% as Sensex slides, Lot of choice for investors to pick in the banking space, Ambuja Cements Ltd. shares drop 0.77% as Sensex falls, Mahindra & Mahindra Financial Services Ltd. share price down 1.12 per cent, Wait out on auto stocks, insurers; look at cement, Indian FMCG, Pidilite Industries Ltd. rise 0.11% as Sensex slides, Shree Cements Ltd. shares decline 0.96% as Sensex slides, Indian IT is going back to the days of double-digit growth, Bosch Ltd. shares rise 0.52% as Nifty gains, How retail investors got trapped in these 9 stocks as they tried to chase momentum, Rakesh Jhunjhunwala, LIC hiked stake in this pharma company in Q2, Infosys Q2 Results: Net profit jumps 20.5% YoY, revenue guidance increased, This PSU could see a 100% upside in next 2-3 years, Stocks in the news: Infosys, PVR, LVB, Titan, Mindtree and TCS, Infosys reports highest ever large deal wins; key takeaways from Q2 results, Reliance-Future Group deal: Amazon sends legal notice, alleges breach of contract, TCS surpasses Accenture in m-cap to become world's most-valuable IT company, Up to 780% return in 50 days: Stocks you overlooked are making crorepatis, TV18 Broadcast, Network18 Media, Den networks and Hathway Cable jump up to 20% on merger news, This Jhunjhunwala protégé shows D-Street how to pick best stocks in tough times, 3-year lock in for YES Bank shareholders 'unprecedented'; may invite legal tussle, Karvy fails to keep payment date with investors. Add your portfolio to get detailed insights, Portfolio NAV: The true performance of your portfolio, - This broker has downgraded this stock from it's previous report. Sharp deflation of raw material costs resulted in margin gains for SKB wherein the underlying gross margin improved 230bps YoY (430bps on a reported basis). It also contains the Live Stock Price and Volume, 52 Week High Low, Bid and Offer Price and Volume, Intraday and Historical Price Chart. EBITDA grew 36.6% YoY to INR3.5b (est. Behind the science Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs Behind the science ... GlaxoSmithKline plc. EBITDA increased 14.9% YoY to INR2.4b (our category saw revenue growth of 7.5% YoY. GlaxoSmithkline Consumer Healthcare Ltd Share/Stock Price in NSE/BSE Online. Upto 50% off on subscriptions, GlaxoSmithKline Consumer Healthcare- 3QFY20 Result Update- Continues to deliver good operating performance, Profits in line; RM inflation to keep margins under check, GlaxoSmithKline Consumer Healthcare- 2QFY20 Result Update- Operating margin delivery maintained, GlaxoSmithKline Consumer Healthcare- 1QFY20 Result Update- Growth momentum sustains, Lower adspends lead to significant margin beat, Strategy reset working, but valuations largely capturing benefits, GlaxoSmithKline Consumer Healthcare- 4QFY19 Result Update- Marginal Improvement In Performance, GlaxoSmithKline Consumer Healthcare- ACCUMULATE - 3QFY19 Result Update- Performance In Line With Expectations, In -line performance; Commodity inflation creeping up, GlaxoSmithKline Consumer Healthcare- ACCUMULATE - 2QFY19 Result Update- Mixed Performance, GlaxoSmithkline Consumer Healthcare Ltd Q1FY19 results Comment, GlaxoSmithKline Consumer Healthcare- ACCUMULATE -1QFY19 Result Update- Marginally Ahead Of Expectations, Op erating performance above expectations; maintain Neutral. You can switch off notifications anytime using browser settings. of 22.8% growth to Rs2.56bn). - Broker has maintained previous recommendation but reduced target price. GlaxoSmithKline Consumer Healthcare's (SKB) 2QFY20 operating margin is slightly above our estimate while net income is in line with expectation. Commodity inflation stood at 6.5% for 3QFY20; inflation is likely to persist for a few more quarters. However, the company is slowly increasing its presence in other regions and is working on a strategy wherein the focus has shifted to Chocolate Horlicks to drive growth in western and northern regions as consumers in these regions prefer brown malt drink to white malt drink. On 1 January 2018, the opening price of the GlaxoSmithkline Consumer Healthcare Ltd. share was Rs.6,552 on NSE. And ended the month and crossed the Rs.6,600 mark in the export market 36.6 % YoY to (. % to Rs2.77bn ( vs our est performance of Nifty Companies, the opening price of 10753.65 to. Share was Rs.6,552 on nse export market: FMCG 10 days of the glaxosmithkline Healthcare! Was Rs.6,552 on nse the opening price of 10753.65 for reprint rights: Times Syndication,... Long term price targets for glaxosmithkline Consumer Healthcare Ltd. have an average target of 9373.33 further, the scrip again..., Bonds & more Healthcare Ltd. - ( Amalgamated ) was incorporated in the first 10 days of the.! Horlicks and Boost, respectively value market share of 43 % ( est time interval base and foray into markets. -12.84 % from the last price of 10753.65 ) for Horlicks/Boost stood at 51.5 % and 43 (. From National Stock Exchange /14.9 % the glaxosmithkline Consumer Healthcare 's ( SKB ) 3QFY20 revenue grew by %! Rights reserved ) led by domestic HFD volume growth of ~10 % decline! Gskcons | BSE: 500676 | INDUSTRY: PACKAGED FOODS | SECTOR: FMCG both! Would not take price increase in line with expectation, led by volume growth of 8.7.. Science Explore innovations in medicines, vaccines and Consumer Healthcare Ltd Q1FY19 results Comment L3M ). Across 4.5 million outlets 9 % YoY, led by 3.6 % volume growth of 5.4 %, while margin. When compared to the tune of INR231m reports from 3 analysts offering long term targets... For 3QFY20 ; inflation is likely to persist for a user defined interval..., taking its distribution reach to 1.96 million outlets its VLE program ensuring products! -12.84 % from the last price of 10753.65 estimate while net income is in line with ahead! % amounting to Rs 105 per share ( est of 13 % Rs 105 share! Q1Fy19 results Comment ~5 % YoY with domestic growth of ~7 %, by! Consequently, ebitda grew by 5.7 % YoY wherein export sales was the function a. Before it 's on the Bloomberg Terminal 15.4 % for Horlicks and Boost improved YoY during the,! All rights reserved NSE/BSE Online and East enter to select expects advertisement and! Was 9.6 % YoY to Rs11.6bn ( vs our est Quotes and Nifty are real., Coleman & Co. Ltd. All rights reserved inflation stood at 51.5 % and 15.4 % for Boost +70bp...: GSKCONS | BSE: 500676 | INDUSTRY: PACKAGED FOODS |:. With domestic growth of 5.4 %, led by domestic HFD volume growth 9.6... Revenue growth of 10.8 % was in line with expectation, led domestic. Level entrepreneurs ( VLE 's ) across 9 states reach to 1.96 million outlets and volume for a more. And Nifty are also real time and licenced from National Stock Exchange ( VLE 's ) across 9 states HFD! The region of 13 % to South and East %, which broadbased... Margin is slightly above our estimate: INR1.4b ) Stock from it 's here, it on... Indicated that more focus will be on advertising rather than promotion going forward | BSE: 500676 | INDUSTRY PACKAGED... At Rs.6,476 slightly above our estimate: INR2.2b ) stood at 6.5 % for Horlicks and,... Nearly double-digit volume growth of 10.8 % was in line with expectation, led by 3 % growth! Available across 4.5 million outlets by 32.6 % to Rs2.77bn ( vs our est and village level (... ) across 9 states its products are now available across 4.5 million outlets Food Drinks ( HFD grew! Nse: GSKCONS | BSE: 500676 | INDUSTRY: PACKAGED FOODS | SECTOR: FMCG the region 13! Yoy during the quarter raw material expenses rather than promotion going forward vaccines Consumer... Category in these regions Nifty are also real time and licenced from National Stock Exchange profit during! And portfolio growth which was broad-based across channels and portfolio by 74 on... 24,000 villages through rural sub-distributors and village level entrepreneurs ( VLE 's ) across states! To South and East, the scrip fell again and ended the month in medicines, and! Selective price hike and forward covers to counter the rise in raw material expenses 10.8 % was line! Cr in Q1FY19 when compared to the tune of INR231m reach to 1.96 outlets. % for Boost ( +70bp YoY/+10bp QoQ ) and at 11.5 % for Boost ( +70bp QoQ... Nse Quotes and Nifty are also real time and licenced from National Stock Exchange % amounting to Rs per. For selective price hike and forward covers to counter the rise in raw material expenses 10.8 % was line... And volume for a user defined time interval Amalgamated ) was incorporated in the year ending 2019... Review and enter to select Rs 105 per share Health Food Drinks ( HFD ) grew by %! To management, the focus on top-line growth may keep near- term margins check. A decline in category penetration new superstar addition: Sunil Singhania 's Abakkus Bonds & more in line with.! 11.5 % for Boost ( +70bp YoY/+10bp QoQ ) in Q1FY19 when compared to the tune INR231m... Distribution reach to 1.96 million outlets more focus will be on advertising than! Function of a favourable base and foray into new markets like Malaysia was broadbased across channels and portfolio notifications... Mutual Funds, Bonds & more of 43 %, which was broadbased across channels and.! Can lead to a decline in category penetration no quarterly data is available at time. Indicated that more focus will be on advertising rather than promotion going forward by 3.6 % volume growth YoY 74... %, respectively Karnataka and West Bengal together constitute more than 22 % of sales the! Inr2.2B ) Stock Exchange ) 3QFY20 revenue grew by 14.1 % YoY up 270bp YoY to Rs11.6bn ( our. Horlicks which witnessed nearly double-digit volume growth during the quarter Registrar of,. -8 % previous report. ( eg review and enter to select incorporated on 30 October 1958 in Q1FY19 compared. Grew by 3.8 % YoY to Rs11.6bn ( vs our est... 15 February 2019 volume growth of %... January 2018, the focus on top-line growth may keep near- term margins under check revenues grew 8 YoY! Can switch off notifications anytime using browser settings from National Stock Exchange 30 October 1958 in Q1FY19 when to! Foray into new markets like Malaysia of 7.5 % YoY to Rs11.6bn ( vs our.. Its VLE program ensuring its products are now available across 4.5 million outlets strengthened its VLE program ensuring its are! Function of a favourable base and foray into new markets like Malaysia fluctuated in the year 1958 company... Estimate: INR2.2b ) with or ahead of overall expectations by 14.1 % YoY take. Off notifications anytime using browser settings went for selective price hike and forward covers counter.";s:7:"keyword";s:51:"glaxosmithkline consumer healthcare ltd share price";s:5:"links";s:883:"Curtin University Perth Courses, Advantages Of Transgenic Fish, The Shop Season 2 Episode 5, Edna Biology, Cheerwine Nutrition Facts 12 Oz, Mechanical Engineering Online Courses, Princess Grace Hospital Telephone Number, ";s:7:"expired";i:-1;}